TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmacosweden AB
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
10,975
|
10,875
|
10,988 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
520
|
519
|
504 |
| EBITDA |
968
|
891
|
816 |
| Total assets |
5,474
|
5,367
|
5,326 |
| Current assets |
3,426
|
4,325
|
4,476 |
| Current liabilities |
2,056
|
2,135
|
2,153 |
| Equity capital |
3,418
|
3,232
|
3,173 |
| - share capital |
63
|
66
|
72 |
| Employees (average) |
9
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
62.4%
|
60.2%
|
59.6% |
| Turnover per employee |
1,219
|
1,208
|
1,221 |
| Profit as a percentage of turnover |
4.7%
|
4.8%
|
4.6% |
| Return on assets (ROA) |
9.5%
|
9.7%
|
9.5% |
| Current ratio |
166.6%
|
202.6%
|
207.9% |
| Return on equity (ROE) |
15.2%
|
16.1%
|
15.9% |
| Change turnover |
491
|
853
|
3,254 |
| Change turnover % |
5%
|
9%
|
42% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
29% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.